Form 4: Nuvalent CSO Exercises Stock Options

Nuvalent's Chief Scientific Officer, Henry E. Pelish, exercised stock options to acquire 5,085 shares of Class A Common Stock.

Summary

• Henry E. Pelish, Chief Scientific Officer of Nuvalent, Inc. (NUVL), exercised stock options on December 22, 2025.
• The transaction involved the acquisition of 5,085 shares of Class A Common Stock at an exercise price of $1.08 per share.
• Following this transaction, Mr. Pelish directly beneficially owns 71,048 shares of Class A Common Stock.
• The exercised stock option was a 'Right to Buy' with an exercise price of $1.08 and an expiration date of February 16, 2031.
• The shares underlying this option were fully vested prior to the exercise.

Sentiment

Score: 7

Explanation: Slightly positive, as it indicates insider confidence and increased direct ownership, which is generally viewed favorably by investors, though it is a routine transaction.

Positives

• The Chief Scientific Officer increased his direct beneficial ownership in the company, which can signal confidence in Nuvalent's future prospects.
• The transaction was executed pursuant to a Rule 10b5-1(c) plan, indicating a pre-planned and systematic approach to insider transactions.

Future Outlook

This filing is a report of an insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

Insider transactions, such as stock option exercises, are common occurrences in publicly traded companies. When officers exercise options and increase their direct ownership, it is often interpreted by the market as a sign of management's belief in the company's long-term value, particularly in the biotechnology sector where long development cycles are common.

Comparison to Industry Standards

• This Form 4 filing details an individual insider transaction and does not provide financial or operational results that can be directly compared to global industry benchmarks or specific comparable companies, projects, and results.

Stakeholder Impact

• Shareholders may view the increased insider ownership as a positive signal of management's alignment with shareholder interests and confidence in the company's future.

Key Dates

Keywords

Nuvalent, NUVL, Stock Option Exercise, Insider Transaction, Form 4, Chief Scientific Officer, Equity Acquisition, Rule 10b5-1